Serveur d'exploration Tocilizumab - Checkpoint (PubMed)

Index « MedMesh.i » - entrée « Peptide Fragments »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Peptic Ulcer < Peptide Fragments < Peptide Library  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 9.
Ident.Authors (with country if any)Title
000805 (2018) I. Yokoe [Japon] ; H. Kobayashi [Japon] ; Y. Kobayashi [Japon] ; J T Giles [États-Unis] ; K. Yoneyama [Japon] ; N. Kitamura [Japon] ; M. Takei [Japon]Impact of tocilizumab on N-terminal pro-brain natriuretic peptide levels in patients with active rheumatoid arthritis without cardiac symptoms.
000972 (2017) Roberta Gualtierotti [Italie]Understanding cardiovascular risk in rheumatoid arthritis: Still a long way to go.
000999 (2017) Yi-Ming Chen [Taïwan] ; Hsin-Hua Chen [Taïwan] ; Wen-Nan Huang [Taïwan] ; Tsai-Ling Liao [Taïwan] ; Jun-Peng Chen [Taïwan] ; Wen-Cheng Chao [Taïwan] ; Ching-Tsai Lin [Taïwan] ; Wei-Ting Hung [Taïwan] ; Chia-Wei Hsieh [Taïwan] ; Tsu-Yi Hsieh [Taïwan] ; Yi-Hsing Chen [Taïwan] ; Der-Yuan Chen [Taïwan]Tocilizumab potentially prevents bone loss in patients with anticitrullinated protein antibody-positive rheumatoid arthritis.
000E70 (2016) Paul Welsh [Royaume-Uni] ; Katie Tuckwell [Royaume-Uni] ; Iain B. Mcinnes [Royaume-Uni] ; Naveed Sattar [Royaume-Uni]Effect of IL-6 receptor blockade on high-sensitivity troponin T and NT-proBNP in rheumatoid arthritis.
001415 (2014) Tetsuo Kobayashi [Japon] ; Moe Okada ; Satoshi Ito ; Daisuke Kobayashi ; Kohei Ishida ; Anri Kojima ; Ichiei Narita ; Akira Murasawa ; Hiromasa YoshieAssessment of interleukin-6 receptor inhibition therapy on periodontal condition in patients with rheumatoid arthritis and chronic periodontitis.
001514 (2013) Anne Sofie Siebuhr ; Anne C. Bay-Jensen ; Diana J. Leeming ; Adam Plat ; Inger Byrjalsen ; Claus Christiansen ; Désirée Van De Heijde ; Morten A. KarsdalSerological identification of fast progressors of structural damage with rheumatoid arthritis.
001A07 (2010) Patrick Garnero [France] ; Elizabeth Thompson ; Thasia Woodworth ; Josef S. SmolenRapid and sustained improvement in bone and cartilage turnover markers with the anti-interleukin-6 receptor inhibitor tocilizumab plus methotrexate in rheumatoid arthritis patients with an inadequate response to methotrexate: results from a substudy of the multicenter double-blind, placebo-controlled trial of tocilizumab in inadequate responders to methotrexate alone.
001A70 (2009) Yukio Mano [Japon] ; Kiyosumi Shibata ; Seiji Sumigama ; Hiromi Hayakawa ; Kazuhiko Ino ; Eiko Yamamoto ; Hiroaki Kajiyama ; Akihiro Nawa ; Fumitaka KikkawaTocilizumab inhibits interleukin-6-mediated matrix metalloproteinase-2 and -9 secretions from human amnion cells in preterm premature rupture of membranes.
001C95 (????) Satoshi Suzuki [Japon] ; Souichiro Nakano [Japon] ; Seiichiro Ando [Japon] ; Ran Matsudaira [Japon] ; Yoshinori Kanai [Japon] ; Kenjiro Yamanaka [Japon] ; Yoshinari Takasaki [Japon]Hepcidin-25 gives an indication of the therapeutic effectiveness of tocilizumab in rheumatoid arthritis - Relationship between disease activity of rheumatoid arthritis and anemia.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/PubMed/Checkpoint
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/MedMesh.i -k "Peptide Fragments" 
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/MedMesh.i  \
                -Sk "Peptide Fragments" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    indexItem
   |index=    MedMesh.i
   |clé=    Peptide Fragments
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021